In addition to a negative baseline biopsy, inclusion criteria were based on factors that placed these men at high risk of prostate cancer including age, slightly elevated serum PSA levels (2.5 to 10.0 ng/mL), or previous prostate biopsies due to suspected cancer. The gene discussed is KLK3; the disease is prostate carcinoma.